Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization
- 14 October 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 269 (2) , 249-254
- https://doi.org/10.1016/0922-4106(94)90093-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- GH3 cells, an anterior pituitary cell line, express CCK-B receptorsPeptides, 1993
- Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell lineEuropean Journal of Pharmacology, 1992
- Cholecystokinin antianalgesia: safety cues abolish morphine analgesiaScience, 1992
- Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activityEuropean Journal of Pharmacology, 1991
- Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic propertiesJournal of Medicinal Chemistry, 1991
- Postponement of Satiety by Blockade of Brain Cholecystokinin (CCK-B) ReceptorsScience, 1989
- N-Methyl-d-aspartate-sensitive [3H]glutamate binding sites in brain synaptic membranes treated with Triton X-100Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976